Skip to main content
Home
  • About Us
    • Our Credo
    • Board of Directors
      • Committees of Board
    • Management Council
    • Manufacturing
    • Quality
    • Code of Conduct
    • Our History - Cipla Archives
      • Scientist with a Heart- Dr. Y K Hamied
    • 90 years of caring for life
    • Legacy of Care | Comic Book
    • Milestones and Awards
  • Our Presence
    • Australia
    • Brazil
    • Europe
    • Germany
    • Ghana
    • Kenya
    • Malaysia
    • Morocco
    • Nepal
    • South Africa
    • Spain
    • Sri Lanka
    • Uganda
    • United Kingdom
    • USA
  • Our Offerings
    • Our Therapies
      • Respiratory
        • Asthma
        • Paediatric Asthma
        • COPD
        • Nebulization
      • HIV/AIDS
      • Oncology
      • Other Therapies
    • AMR
    • Cipla Generics
      • Products
        • Cipcal
        • Easylax
        • Easylax-L
    • OTC – Cipla Health
    • Cipla Diagnostics
    • API
    • Covid Care
  • Investors
    • Financials & Filings
      • Quarterly Results
      • Investor Presentation
      • Annual Reports
      • Scheme of Arrangement
    • Disclosure under regulation 46 of SEBI LODR
    • Corporate Governance
    • Cipla at a Glance
      • Board Of Directors
    • Investor Resources
    • Shareholding Pattern
    • Intimation to Stock Exchange
    • Unclaimed Data
    • Investor Contacts
    • Disclaimer
  • Sustainability
    • Championing Climate Positivity
    • Accelerated Community Well-being
      • Community Initiatives
      • Employee Initiatives
    • Raising the Bar on Governance
    • Enhancing Access and Affordability
    • ESG Profile
  • Careers
    • Life at Cipla
    • Business Functions
    • Diversity & Inclusion
    • Holistic Wellbeing
    • Cipla University
    • Join Us
  • Media Releases
  • Corporate Social Responsibility
    • Cipla Foundation
    • Cipla Palliative Care
      • Annual Update 2025
      • Annual Update 2023-24
    • CSR Policy
    • CSR Committee
    • Approved CSR Projects
      • 2025-26
      • 2024-25
      • 2023-24
      • 2022-23
      • 2021-22
  • Contact Us
  • Global
    • Brazil
    • Kenya
    • South Africa
    • Sri Lanka
    • United Kingdom
    • USA

Breadcrumb

  • Home
  • careers
  • life cipla
life-at-cipla

Life at Cipla

Quick Explore

  • Culture and values

Glimpses from the ALT-SS Premier League

Cipla Indore - Blood Donation Camp

Cipla Fest Goa

Cipla Alive Tech Campus Program

Glimpses from CipPact

Quarterly Global Townhall

  • +

Corporate Information

  • About Us
  • Scientist with a Heart- Dr. Y K Hamied
  • 90 years of caring for life
  • Milestones and Awards

Our Presence

  • Our Presence
  • Australia
  • Brazil
  • Europe
  • Germany
  • Ghana
  • Kenya
  • Malaysia
  • Morocco
  • Nepal
  • South Africa
  • Spain
  • Sri Lanka
  • Uganda
  • United Kingdom
  • USA

Our Offerings

  • Our Offerings
  • Our Therapies
  • Respiratory
  • Asthma
  • COPD
  • Nebulization
  • Paediatric Asthma
  • HIV/AIDS
  • Oncology
  • Other Therapies
  • AMR
  • Cipla Generics
  • Products
  • Cipcal
  • Easylax
  • Easylax-L
  • OTC – Cipla Health
  • Cipla Diagnostics
  • API
  • Covid Care

Sustainability

  • Sustainability
  • Accelerated Community Well-being
  • Championing Climate Positivity
  • Community Initiatives
  • Employee Initiatives
  • Enhancing Access and Affordability
  • Raising the Bar on Governance
  • ESG Profile

Investor Information

  • Investors
  • Financials & Filings
  • Quarterly Results
  • Investor Presentation
  • Annual Reports
  • Scheme of Arrangement
  • Corporate Governance
  • Disclosure under regulation 46 of SEBI
  • Cipla At a Glance
  • Investor Resources
  • Shareholding Pattern
  • Intimation to stock Exchanges
  • Unclaimed Data
  • Investor Contact
  • Disclaimer

Media

  • Media Center
  • Media Releases

Career Sitemap

  • Careers
  • Life at Cipla
  • Business Functions
  • Diversity & Inclusion
  • Holistic Wellbeing
  • Cipla University
  • Join Us

Corporate Social Responsibility

  • CSR-Cipla Foundation
  • Cipla Palliative Care
  • Annual Update 2023-24
  • CSR Policy
  • CSR Committee
  • Approved CSR Projects
  • - 2024-25
  • - 2023-24
  • - 2022-23
  • - 2021-22

Quick Links - Footer

  • Privacy Policy
  • Disclaimer
  • Contact Us
  • Sitemap
  • Beware of Recruitment Fraud
  • Drug Safety Reporting

Chatbot API

  • Terms & Condition
  • Privacy Policy
  • Disclaimer
  • Terms of Use

Related Links

  • breathefree.com
  • ciplamed.com

© Copyright 2019 Cipla. All rights reserved

Digital Partner : Indus Net Technologies

  •  
  •  
  •  
  •  

Subscribe to Cipla Newsletter

  •  
  •  
  •  
  •  
  •  

Mobile Footer Menu

  • Remdesivir Supply Details - Maharashtra
  • Caution Notice - "Recruitment Fraud"
  • Contact Us
  • Disclaimer
  • Privacy Policy

© Copyright 2019 Cipla. All rights reserved

×

We use cookies on this site to enhance your user experience

By continuing to browse our website, you agree to the use of cookies. More info

Accept All Cookies
Reject Cookies
Manage Preferences

Cookie Preferences

×
Save Preferences